# Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older

> **NCT00765076** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 192 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** GSK Biologicals' influenza vaccine GSK2186877A
- **BIOLOGICAL:** GSK Biologicals' Fluarix

## Key facts

- **NCT ID:** NCT00765076
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10-16
- **Primary completion:** 2009-12-04
- **Final completion:** 2009-12-04
- **Target enrollment:** 192 (ACTUAL)
- **Last updated:** 2018-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00765076

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00765076, "Clinical Study of the Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2186877A in People Aged 65 Years or Older". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00765076. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*